ADHD Drug Recall Issued by FDA

A voluntary recall has been issued by generic drug maker Barr Laboratories for the following medications which are typically used to treat symptoms of attention deficit and hyperactivity disorder (ADHD):

"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product) 20milligram Tablets, 100 count bottles, lot number 311756. The product identified is being recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets."

Adverse reactions could include: cardiovascular, neurologic, psychiatric and gastrointestinal reactions such as: palpitations, tachycardia, hypertension, headache, tremor, tic, dyskinesia, dizziness, blurred vision, sweating, insomnia, agitation, euphoria, mania, anxiety, restlessness, nausea, diarrhea, constipation, dry mouth, and decreased appetite.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Leave this field blank

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By submitting this form, you agree to EmpowHER's terms of service and privacy policy

Tags

• Attention Deficit Hyperactivity Disorder (ADHD)
• Political Issues